Substitution therapy after surgery for autonomous adenomas

Citation
J. Feldkamp et Wa. Scherbaum, Substitution therapy after surgery for autonomous adenomas, EXP CL E D, 106, 1998, pp. S85-S87
Citations number
33
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
ISSN journal
09477349 → ACNP
Volume
106
Year of publication
1998
Supplement
4
Pages
S85 - S87
Database
ISI
SICI code
0947-7349(1998)106:<S85:STASFA>2.0.ZU;2-H
Abstract
A substitution therapy with L-thyroxine subsequent to surgery on the thyroi d gland due to autonomous dysfunction depends in particular on the extent o f resection. A specific postoperative therapy is not necessary in areas wit h sufficient iodine supply if the remaining part of the thyroid gland guara ntees a euthyroid metabolic state. The radicalness of the intervention is d ependent on the existence of an unifocal, multifocal or disseminated autono my. Surgery due to disseminated autonomy always necessitates a substitutive therapy with thyroid hormones and in most cases surgery due to multifocal autonomies require the same treatment. The therapy is initiated with a dose of 1.5 mu g L-thyroxine per kg body weight. Suppression of the TSH level i s not necessary. Due to the greater risk of recurrence the L-thyroxine admi nistration should be complemented in areas of iodine deficiency with approx imately 100 - 200 mg iodide. After operations with functionally adequate th yroid remnants (8 - 10 mi), an exclusive prophylaxis with 200 mg iodide can be implemented. The result of surgery should be sonographically documented three months after the intervention.